Atlas Trials

Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction

Clinical trial NCT03165292 · TERMINATED

Trial details

NCT number
NCT03165292
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Very High Risk Neuroblastoma
Start date
2018-10-01
Primary completion
2023-08-28
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.